✦ LIBER ✦

Bestrophin expression and function in the human pancreatic duct cell line, CFPAC-1

✍ Scribed by Laura L. Marsey; John P. Winpenny

Book ID: 110116297
Publisher: Cambridge University Press
Year: 2009
Tongue: English
Weight: 579 KB
Volume: 587
Category: Article
ISSN: 0022-3751
DOI: 10.1113/jphysiol.2008.159087

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Trypsinogen expression by two human panc

Trypsinogen expression by two human pancreatic cell lines CFPAC-1 and CAPAN-1

✍ Barbara Miszczuk-Jamska; Marc Merten; Wanda Renaud; Odette Guy-Crotte; Catherine 📂 Article 📅 1994 🏛 Springer US 🌐 English ⚖ 844 KB

Characterization of trypsinogens 1 and 2

Characterization of trypsinogens 1 and 2 in two human pancreatic adenocarcinoma cell lines; CFPAC-1 and CAPAN-1

✍ B. Miszczuk-Jamska; M. Merten; O. Guy-Crotte; M. Amouric; F. Clemente; R.A. Scho 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 436 KB

Hypoxiz-Inducible Factor-1α (HIF-1α) Med

Hypoxiz-Inducible Factor-1α (HIF-1α) Mediates Chemokine Receptor CXCR4 Expression Under Hypoxic Condition in Human Pancreatic Cancer Line CFPAC-1

✍ R.H. Grand; G. Sun; J. Chung; C. Meschonat; B.D. Li; Q.D. Chu 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 140 KB

Frequent loss of RUNX3 gene expression i

Frequent loss of RUNX3 gene expression in human bile duct and pancreatic cancer cell lines

✍ Wada, Manabu; Yazumi, Shujiro; Takaishi, Shigeo; Hasegawa, Kazunori; Sawada, Mit 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 237 KB

Concurrent and Independent HCO−3and Cl−S

Concurrent and Independent HCO−3and Cl−Secretion in a Human Pancreatic Duct Cell Line (CAPAN-1)

✍ H.S. Cheng; P.Y. Leung; S.B. Cheng Chew; P.S. Leung; S.Y. Lam; W.S. Wong; Z.D. W 📂 Article 📅 1998 🏛 Springer 🌐 English ⚖ 255 KB

Serial in vivo loss and in vitro gain of

Serial in vivo loss and in vitro gain of Fas expression and function in human cancerous pancreatic duct cells

✍ Soroosh Radfar; Christian Davrinche; Etienne Hollande 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 French ⚖ 512 KB

## Abstract Recent studies have shown the involvement of the Fas system (Fas receptor and its ligand FasL) in cancerous processes. The absence or downregulation of Fas, reported in the majority of human tumors, conflicts with its presence in cancerous cells from the same tumors but maintained __in